Literature DB >> 11798784

[Association between genetic polymorphism of dopamine transporter gene and susceptibility to Parkinson's disease].

J Wang1, Z Liu, B Chen.   

Abstract

OBJECTIVE: To explore the association between genetic polymorphism of dopamine transporter (DAT) gene and susceptibility to Parkinson's disease (PD).
METHODS: The polymorphism of DAT 3' VNTR was analyzed in 171 PD patients and 180 unrelated healthy controls with amplification fragment length polymorphism (Amp-FLP).
RESULTS: Five alleles of the DAT 3' VNTR were detected, consisting of 7, 8, 9, 10 and 11 copies of the 40 bp repeated sequence. The 10-copy allele was the most common one in both patients and controls. There were significant differences in both allelic and genotypic distributions of the DAT 3' VNTR between the patient and control groups (P = 0.016, P = 0.03, respectively; Fisher's exact test). The frequency of the 11-copy allele was significantly higher in patients (4.4%) than in controls (1.1%), with an odds ratio of 4.08 (95% confidence interval 1.25 approximately 14.7, P = 0.008).
CONCLUSION: DAT 3' VNTR 11-copy allele is a genetic factor susceptible to PD in the population tested.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11798784

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  3 in total

Review 1.  Psychosis in Parkinson's Disease: A Lesson from Genetics.

Authors:  Efthalia Angelopoulou; Anastasia Bougea; Sokratis G Papageorgiou; Chiara Villa
Journal:  Genes (Basel)       Date:  2022-06-20       Impact factor: 4.141

2.  SLC6A3 is a risk factor for Parkinson's disease: a meta-analysis of sixteen years' studies.

Authors:  Desheng Zhai; Songji Li; Ying Zhao; Zhicheng Lin
Journal:  Neurosci Lett       Date:  2013-11-07       Impact factor: 3.046

Review 3.  "Reframing" dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications.

Authors:  Bianca Marchetti; Carmela Giachino; Cataldo Tirolo; Maria F Serapide
Journal:  Aging Cell       Date:  2022-03-09       Impact factor: 9.304

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.